Clinical Trial Update: Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Lotilaner ophthalmic gel for ocular rosacea is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Rosacea

Drugs mentioned

• Lotilaner Ophthalmic Gel (lotilaner)

Snippet

Sponsor: Tarsus Pharmaceuticals, Inc. | Conditions: Ocular Rosacea | Phase 2 | Status: ENROLLING_BY_INVITATION